Home > News > Rexahn, university partner for drug development
March 4th, 2006
Rexahn, university partner for drug development
Abstract:
The University of Maryland has teamed with Rexahn Pharmaceuticals to improve the company's drugs that treat cancer and central nervous system disorders. Researchers from the university's Center for Nanomedicine and Cellular Delivery in Baltimore will work with Rockville-based Rexahn to find new ways of applying nanotechnology research to make more effective drugs.
Source:
ACBJ
Bookmark:
| Related Links |
Center for Nanomedicine and Cellular Delivery
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||